In regards to surgery it is recommended to perform total omentectomy since subclinic metastasis have been documented in 10 - 30 % of all cases , and systematic limphadenectomy , necessary to be able to obtain an adequate surgical staging .
Minimal invasion surgery is not a recommended procedure for the treatment of advanced ovarian cancer .
Radiotherapy can be used to palliate symptoms .
In the present , there is not a st and ardized screening method .
Diagnosis in early stages means a better survival .
Radiotherapy can be indicated to palliate symptoms
INTRODUCTION Ovarian cancer ( OC ) is the third most common gynecologic malignancy worldwide .
Most of cases it is of epithelial origin .
At the present time there is not a st and ardized screening method , which makes difficult the early diagnosis .
The 5-year survival is 90 % for early stages , however most cases present at advanced stages , which have a 5-year survival of only 5 - 20 % .
GICOM collaborative group , under the auspice of different institutions , have made the following consensus in order to make recommendations for the diagnosis and management regarding to this neoplasia .
Until now , laparoscopy for diagnostic-staging surgery is not well known as a recommended method .
In advanced stages , primary cytoreduction is recommended as initial treatment .
Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants.
OBJECTIVES The objectives were to describe the clinical characteristics and prognosis of surgically treated patients with stage II and III serous borderline tumors of the ovary with noninvasive implants .  MATERIAL S AND METHODS From 1990 to 2000 , 16 patients with stage II and III ovarian serous borderline tumors and noninvasive implants  were diagnosed and prospect ively followed at our center . All patients underwent surgical treatment including staging and their pathology was review ed . Fifteen patients had thorough surgical staging by laparotomy , while one patient was staged laparoscopically . No patient was treated with adjuvant therapy ( radiation or chemotherapy ) after surgical treatment and none were lost to follow-up . RESULTS The mean age at diagnosis was 42 years ( range 26 - 59 ) . Fourteen patients were treated by abdominal hysterectomy , bilateral salpingo-oophorectomy , omentectomy , and multiple peritoneal biopsies  , while 2 patients were treated conservatively for fertility preservation . Two patients underwent pelvic and para-aortic lymph node dissection . Fifteen of 16 patients had ovarian surface involvement with tumor . All patients but 2 had clinical evidence of extraovarian disease at the time of surgery . The mean duration of follow-up was 60.7 months ( range 2 - 134 months ) . Thirteen patients ( 81 % ) are alive without evidence of disease . Four patients ( 25 % ) required subsequent surgery for recurrent disease and all are still alive . Two patients have been treated with chemotherapy ( paclitaxel/carboplatin ) for progressive borderline disease , while an additional patient was treated after first relapse with chemotherapy for an invasive recurrence . CONCLUSIONS Carefully staged patients with advanced serous borderline tumors of the ovary and noninvasive implants have a good prognosis without adjuvant therapy
In regards to surgery it is recommended to perform total omentectomy since subclinic metastasis have been documented in 10 - 30 % of all cases , and systematic limphadenectomy , necessary to be able to obtain an adequate surgical staging .
Minimal invasion surgery is not a recommended procedure for the treatment of advanced ovarian cancer .
Radiotherapy can be used to palliate symptoms .
In the present , there is not a st and ardized screening method .
Diagnosis in early stages means a better survival .
Radiotherapy can be indicated to palliate symptoms
INTRODUCTION Ovarian cancer ( OC ) is the third most common gynecologic malignancy worldwide .
Most of cases it is of epithelial origin .
At the present time there is not a st and ardized screening method , which makes difficult the early diagnosis .
The 5-year survival is 90 % for early stages , however most cases present at advanced stages , which have a 5-year survival of only 5 - 20 % .
GICOM collaborative group , under the auspice of different institutions , have made the following consensus in order to make recommendations for the diagnosis and management regarding to this neoplasia .
Until now , laparoscopy for diagnostic-staging surgery is not well known as a recommended method .
In advanced stages , primary cytoreduction is recommended as initial treatment .